SUBOXONE Film is approved for use in both induction and maintenance treatment of opioid dependence in appropriate patients.*
- For dependence on short-acting opioids, like heroin or prescription painkillers, SUBOXONE Film, which contains buprenorphine and naloxone, may be recommended to help you begin and maintain continuity of treatment
- When transitioning from dependence on long-acting opioids, like methadone, a buprenorphine-only medication may be recommended
If a doctor, nurse practitioner or physician assistant waivered to treat opioid dependence prescribes SUBOXONE Film, your treatment can begin. The following are potential stages of treatment with SUBOXONE Film. Only your healthcare provider can decide what is an appropriate treatment plan for you.
- Induction—you begin your treatment (or restart it if you’ve relapsed) under the supervision of a healthcare provider. For your first dose, you must be in a moderate state of withdrawal. You work with your healthcare provider to reach a dose of SUBOXONE Film that works for you.
- Maintenance—Your healthcare provider will help you to transition to the maintenance phase of treatment when you:
- Are no longer experiencing withdrawal symptoms
- Have minimal to no side effects
- Do not have uncontrollable cravings
In the maintenance phase, you may be taking your medication regularly as prescribed. You should comply with all of the elements in your treatment plan including responsibly handling the medication, staying free from illicit drug use, and seeking counseling and/or psychosocial support.
- Medical taper—The decision to discontinue therapy with SUBOXONE Film after a period of maintenance should be made as part of a comprehensive treatment plan. It is important that you work with your doctor, nurse practitioner or physician assistant to determine when the time is right to slowly lower your dose, taking care to minimize withdrawal symptoms. Throughout treatment, you should discuss any concerns you have about relapse with your healthcare provider.
*SUBOXONE Film is not recommended in patients with severe hepatic impairment and may not be appropriate for patients with moderate hepatic impairment. However, SUBOXONE Film may be used with caution for maintenance treatment in patients with moderate hepatic impairment who have initiated treatment on a buprenorphine product without naloxone.
For more information on adverse events click here.